Clinical Features and Outcomes of Spontaneous Bacterial Peritonitis Caused by Streptococcus pneumoniae: A Matched

Taeeun Kim1, Sun In Hong, Se Yoon Park

  • 1From the Department of Infectious Diseases (TK, SIH, SYP, JJ, YPC, S-HK, S-OL, YSK, JHW, S-HC); Department of Gastroenterology (Y-SL); and Department of Laboratory Medicine (HS, M-NK), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Medicine
|June 4, 2016
PubMed

Insights

Spontaneous pneumococcal peritonitis (SPP) in cirrhotic patients is not linked to pneumonia and has lower mortality than other SBP causes. Further research is needed to confirm SPP

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Microbiology

Background:

  • Streptococcus pneumoniae is a known cause of spontaneous bacterial peritonitis (SBP) in patients with cirrhosis.
  • Limited data exists on the clinical features and outcomes of SBP specifically caused by S. pneumoniae (SPP).
  • SPP is hypothesized to arise from hematogenous spread of pneumococcal pneumonia, potentially leading to higher mortality.

Purpose of the Study:

  • To investigate the clinical characteristics and outcomes of spontaneous pneumococcal peritonitis (SPP) in cirrhotic patients.
  • To compare SPP cases with SBP cases caused by other organisms.
  • To determine the association between SPP and pneumococcal pneumonia.

Main Methods:

  • A retrospective study identified 50 cases of SPP between January 1997 and December 2013.
  • SPP cases were age/sex-matched with 100 control patients with SBP from other causes.
  • Clinical data, including infection source, comorbidities, treatment, and mortality, were analyzed.

Main Results:

  • SPP constituted 4.3% of all culture-proven SBPs.
  • SPP patients were more likely to have community-acquired infections, concurrent bacteremia, and variceal bleeding compared to controls.
  • Thirty-day mortality was significantly lower in SPP patients (10.0%) than in controls (24.0%).
  • None of the SPP patients had concurrent pneumococcal pneumonia.
  • Third-generation cephalosporins showed high activity against SPP pathogens.

Conclusions:

  • Spontaneous pneumococcal peritonitis (SPP) in cirrhotic patients is not associated with pneumococcal pneumonia.
  • SPP demonstrates a lower 30-day mortality rate compared to SBP caused by other microorganisms.
  • Larger, controlled studies are necessary to definitively establish the impact of SPP on mortality due to the limitations of this retrospective analysis.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
2
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.4K